Virtual event

Labroots Announces 5th Annual Virtual Cannabis Science Event, Featuring New Track “Hot Topics” Covering Psychedelics and THC Isomers, Due March 23, 2022

Cannabis Sciences Virtual Event, March 23, 2022

Labroots, the leading scientific social networking website offering leading virtual events and interactive webinars, today announced Cannabis Sciences 2022, taking place on March 23 with an outstanding lineup of leading experts covering sessions such as Medical Cannabis – Therapeutic Updates, The Changing Regulatory Landscape, Analytics, Testing and Automation, Advances in Cultivation and Extraction Methods, and Hot Topics.

Entering its 5th consecutive year, the free online event continues to raise the bar for showcasing scientific discoveries and insightful discussions about cannabis globally. This year, the overall theme of the event is “Cannabis and Hemp are Changing the Global Future”, bringing together thousands of researchers, leading academics and industry professionals, scientists, instrument makers, doctors, laboratory experts to learn more about the latest advances in the field. evolving field of cannabis science.

The conference agenda will feature two stellar keynotes from Dr. Dustin Sulak, Founder and Medical Director, Integr8 Health and Co-Founder of Healer.com, and Dr. Jeff Chen, Chief Executive Officer and Co-Founder by Radicle Science. Dr. Sulak will summarize preclinical findings on acidic cannabinoids and provide practical strategies for clinicians and patients to harness the power of raw cannabis during his keynote titled “Acid Cannabinoids: Inactive Precursors or Potent Therapeutics”, followed by a live question-and-answer session. Next, Dr. Jeff Chen will discuss current knowledge about the therapeutic potential of CBD and also assess the current regulatory landscape during his presentation entitled “Preliminary Results of the Radicle Science ACES Study, the largest longitudinal trial of CBD products in the world. story, with live Q&A.

Dr. Dustin Sulak, Founder and Medical Director of Integr8 Health and Co-Founder of Healer.com said, “Cannabis is a well-known treasure trove of medicinal compounds with therapeutic potential. Surprisingly, some of its most abundant constituents, acidic cannabinoids, have long been overlooked and dismissed as inactive precursors. My clinical experience and the scientific literature have shown that these compounds are far from inactive and in fact have valuable therapeutic effects. THCA and CBDA have overlapping and other distinct properties compared to their more well-known counterparts, THC and CBD, but most people don’t know how to take advantage of these non-harmful cannabinoids. I’m excited to share a review of the literature and practical tips for use with the Labroots audience so that more people can access the power of raw cannabis. »

Dr. Jeff Chen, Founder and Former Executive Director of the UCLA Cannabis Research Initiative, and Co-Founder/CEO of Radicle Science, said, “Non-prescription cannabinoids are currently used by as many as 50 million Americans, but due to nearly a century of regulatory restrictions that persist to this day, we have little clinical trial data on their effectiveness. Via Labroots’ virtual platform, I’m excited to highlight Radicle Science’s unique direct-to-consumer virtual clinical trial approach and discuss recent results from our ACES (Advancing CBD Education & Science) study – the most largest clinical trial of non-prescription CBD products in history involving nearly 3,000 Americans in all 50 states.

Rounding out the day, attendees will explore topics such as debunking myths and misconceptions about the psychedelic industry, the use of polysaccharide-based chiral stationary phases for achiral and chiral separation of cannabinoids, liquid chromatography – discovery of tandem mass spectrometry and anthocyanin flavonoid profiling in cannabis, struggling to keep up with new USDA hemp testing rules: LIMS makes it easier, overcoming challenges associated with analysis of Colorado state-regulated pesticides in hemp using a new LC/MS/MS method with dual source ESI and APCI, ubiquity of microbes: the myth of sterile cultivation systems, to name a few- one.

“We are thrilled to host our 5th virtual Cannabis Sciences event highlighting such renowned presenters bringing cutting-edge science to the fore,” said Greg Cruikshank, CEO of Labroots. “Labroots continues its strong tradition of showcasing the latest trends in cannabis therapy as well as advances in hemp science, and we look forward to sharing these discoveries, medical research, new approaches and regulations with the scientific community. as we shape the future of the cannabis industry.

Produced on Labroots’ interactive platform while connecting to all desktop and mobile devices, the online environment offers one-stop collaboration including a lobby with ranking and gamification, an auditorium with video webcasts live and live chats during scheduled presentations, a poster room to explore data and also participate in live discussions, an exhibition hall and a networking lounge to communicate with colleagues, including a wall media center and a photo booth, providing an enriched learning experience for all attendees. Attendees can earn one continuing education credit (per presentation) for a maximum of 40 credits.

For more information or to register for the event for free, click here. Use #LRcannabis to follow the conversation online!

About Labroots

Labroots is the leading science social networking website and leading source for science news and leading virtual events and educational webinars and more. Advancing science through content sharing capabilities, Labroots is a powerful advocate for amplifying global networks and communities. Founded in 2008, Labroots focuses on digital innovation in scientific collaboration and learning. Offering more than articles and webcasts that go beyond the mundane and explore the latest discoveries in the world of science, Labroots users can stay at the top of their field by earning continuing education credits on a wide range of topics through their participation in webinars and virtual events.

Share the article on social networks or by e-mail: